Back to results
CompletedPhase 2

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

NCT00296946

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Toronto Western Hospital, University Health Network

Toronto, Ontario, Canada

View on ClinicalTrials.gov
Ipratropium Spray for Drooling Saliva in Parkinson's Disease — TrialFind